Have a feature idea you'd love to see implemented?
Let us know!
STIM Neuronetics Inc
Price (delayed)
$0.9836
Market cap
$29.8M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.11
Enterprise value
$49.78M
Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its commercial
Highlights
The revenue has grown by 6% YoY
The gross profit has grown by 3.7% YoY
STIM's equity has dropped by 57% year-on-year and by 30% since the previous quarter
The company's debt has surged by 56% YoY
Key stats
What are the main financial stats of STIM
Market
Valuations
Earnings
Shares outstanding
30.3M
Market cap
$29.8M
Enterprise value
$49.78M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.52
Price to sales (P/S)
0.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.69
Revenue
$72.07M
EBIT
-$25.64M
EBITDA
-$23.52M
Free cash flow
-$27.4M
Per share
Balance sheet
Liquidity
EPS
-$1.11
Free cash flow per share
-$0.91
Book value per share
$0.65
Revenue per share
$2.4
TBVPS
$3.22
Total assets
$96.81M
Total liabilities
$77.43M
Debt
$62.62M
Equity
$19.39M
Working capital
$46.25M
Debt to equity
3.23
Current ratio
2.58
Quick ratio
2.15
Net debt/EBITDA
-0.85
Margins
Efficiency
Dividend
EBITDA margin
-32.6%
Gross margin
73.3%
Net margin
-45.1%
Operating margin
-39.8%
Return on assets
-31.7%
Return on equity
-109%
Return on invested capital
-27.5%
Return on capital employed
-38%
Return on sales
-35.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STIM stock price
How has the Neuronetics stock price performed over time
Intraday
-1.64%
1 week
7.39%
1 month
11.77%
1 year
-7.21%
YTD
-66.08%
QTD
29.46%
Financial performance
How have Neuronetics's revenue and profit performed over time
Revenue
$72.07M
Gross profit
$52.8M
Operating income
-$28.66M
Net income
-$32.47M
Gross margin
73.3%
Net margin
-45.1%
The company's net margin fell by 20% QoQ but it rose by 2.4% YoY
The net income has contracted by 18% from the previous quarter and by 3.7% YoY
The company's operating margin rose by 17% YoY but it fell by 6% QoQ
STIM's operating income is up by 12% YoY but it is down by 4.2% from the previous quarter
Growth
What is Neuronetics's growth rate over time
Valuation
What is Neuronetics stock price valuation
P/E
N/A
P/B
1.52
P/S
0.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.69
STIM's EPS is down by 17% from the previous quarter
STIM's equity has dropped by 57% year-on-year and by 30% since the previous quarter
STIM's price to book (P/B) is 45% less than its last 4 quarters average of 2.8 and 38% less than its 5-year quarterly average of 2.5
The P/S is 81% below the 5-year quarterly average of 2.2 and 62% below the last 4 quarters average of 1.1
The revenue has grown by 6% YoY
Efficiency
How efficient is Neuronetics business performance
The ROE has plunged by 86% YoY and by 44% from the previous quarter
STIM's ROIC is up by 31% YoY but it is down by 17% from the previous quarter
STIM's ROS is down by 21% from the previous quarter but it is up by 9% YoY
The return on assets has declined by 19% since the previous quarter and by 11% year-on-year
Dividends
What is STIM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STIM.
Financial health
How did Neuronetics financials performed over time
The total assets is 25% more than the total liabilities
STIM's current ratio has plunged by 54% from the previous quarter and by 50% YoY
Neuronetics's quick ratio has plunged by 54% from the previous quarter and by 48% YoY
STIM's equity has dropped by 57% year-on-year and by 30% since the previous quarter
The company's debt has surged by 56% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.